Abstract. Several 
thyroid function after treatment of thyrotoxicosis. However, the association between certain DR antigens and the outcome of thyroid function years after radioiodine treatment for Graves' disease remains unclear. We therefore determined the HLA pattern in 2 groups of female patients with different severity of hypothyroidism. From a total of 45 patients, 27 had developed pre-clinical hypothyroidism ( A, n.s.). The whole group of Graves' disease patients showed the antigens B8, DR3 and Drw6 in 37.8%, 33.3% and 35.6%, respectively (P < 0.02, < 0.05, and < 0.04 vs controls). In patients with pre-clinical hypothyroidism there was a significantly increased prevalence of antigen B8 (P < 0.01) and DR3 (P < 0.05) compared to the control group. In contrast, the overt hypothyroid group showed an augmented frequency of HLA-DRw6 (P < 0.04). Antibody positivity was related to the antigens B8 and DR3 (P < 0.005, < 0.03, respectively). Thus, the presence of B8/DR3 represents a genetic pattern possibly protecting against the development of overt hypothyroidism, at least over several years after 131I-treatment. The presence of DRw6 and the absence of DR3 were associated with an increased risk for overt post-irradiation hypothyroidism.
Autoimmune thyroid disease is related to organ specific deficiency in suppressor T-lymphocytes followed by an immune response to autoantigens (Strakosch et al. 1982; Mitchison 1985) . The hu¬ man leucocyte antigen (HLA) system seems to be involved in the control of such immune responses (Farid & Bear 1981; Mitchison 1985) . The associa¬ tion between HLA-B8 and -DR3 with Graves' disease in Caucasoids is generally accepted (Farid & Bear 1981; Farid et al. 1975; Chopra et al. 1977; Bech et al. 1977; Lamberg 1979 ). They showed normal serum levels of T4, FT4, and T3, normal or elevated basal TSH levels but an exaggerated TSH response to oral TRH (normal peak TSH 3 h after oral TRH in 32 healthy female volunteers: xlog 16.8 mU/1; ± 2 SD log = 7.5-37.3 mU/1). These patients received no hormone replacement therapy.
Group
Eighteen patients with overt hypothyroidism (T4, FT4 levels in the hypothyroid range, normal or diminished T3 levels, and elevated basal TSH concentrations) re¬ ceived replacement therapy with thyroxine.
The mean age did not differ significantly in the two groups (56.8 ± 7 in group A vs 60 ± 10 years in group B, n.s.). The mean total dose of radioiodine adminis¬ tered was similar in both groups (6.0 ± 2 (range 4-10) vs 7.4 ± 3 (3-12) mCi; n.s.). The applied dose of 131I was calculated in each patient in order to achieve approximately 6000 rad in the thyroid tissue, taking into account the estimated weight of the thyroid gland, the effective half-life, and the maximal iodine uptake (Jackson 1975 Fig. 1 ). DRw6 was not significantly different. In contrast the overt hypothyroid group had a significant elevation of DRw6 (P < 0.04), but the frequencies of the antigens B8 and DR3 did not differ compared to controls (Table IB, Fig. 1 ).
The frequencies of HLA-B8, DR3 and DRw6 according to the thyroid antibody state are shown in Table IC . We found a significant relationship between antibody positivity and antigens 8 and DR3 (P < 0.005, < 0.03, respectively vs controls). On the other hand, antibody negative subjects showed a clearly elevated DRw6 frequency (P<0.01).
We could find no further significant relation between other DR antigens and Graves' disease. HLA-DR2 was slightly augmented in the whole group of patients and was most frequent in the antibody negative group (40% vs 22% in controls, n.s.).
There was no difference in the pattern of HLA antigens in the presence or absence of endocrine ophthalmopathy.
Discussion
Of our Graves' disease patients 38% were positive for HLA-B8, which is in good agreement with earlier studies in caucasoid patients (Farid et al. 1975; Chopra et al. 1977; Bech et al. 1977; Thorsby et al. 1975 ). DR3 which is in linkage disequilibrium with B8 has a somewhat lower prevalence in our patients (33%) than reported by other investigators (Farid et al. 1979 (Farid et al. , 1980 (Farid et al. , 1981 Bech et al. 1977; Thorsby et al. 1975; Schleusener et al. 1983) and confers a relative risk of 2.6. The reasons for the less strong association of DR3 than B8 may be related to the fact that older patients are selected for treatment with radioiodine (Farid et al. 1980 
